Skip to main content
OpenTrials
Completed

NCT Number: NCT03887767

sST2 and Cardiac Surgery

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery.

The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 80
  • cardiac surgery includind coronary arterial bypass of valvular surgery

Exclusion criteria

  • other surgery

Treatment and study plan

Primary outcomes

  1. Mortality rate

    Time frame: 1 year

    1 year mortality rate

Secondary outcomes

  1. Number of rehospitalisation

    Time frame: 1 day

    Number of rehospitalisation

  2. Number of cardiac events

    Time frame: 1 day

    Number of cardiac events

  3. Number of cardiac stroke

    Time frame: 1 day

    Number of cardiac stroke

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Prognostic Value of sST2 in Cardiac Surgery on Long Term Morbimortality

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Mar 25, 2019
Registry last updated
Mar 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.